Article
[Thrombosis in myeloproliferative neoplasms].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2000
Asakura Hidesaku
Abstract excerpt
Among all types of myeloproliferative neoplasms (MPNs), polycythemia vera (PV) and essential thrombocythemia (ET) require careful management of both thrombosis and hemostasis. One recent concern associated with MPNs is the JAK2 mutation (V617F). This mutation is essential for MPN pathology, but it has also garnered attention for its association with thrombosis. Several studies have reported the mechanisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
